This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignees: Alivexis, Inc., Astellas Pharma Gmbh. Active years: 2026.
Company Filing History:
1 out of 1 
1 out of 424 
Years Active: 2026
Title: Takeo Urakami: Innovator in Pharmaceutical Chemistry
Introduction
Takeo Urakami is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on azacycloalkyl carbonyl cyclic amine compounds. His research focuses on developing active ingredients for treating inflammatory diseases associated with neutrophils.
Latest Patents
Takeo Urakami holds 1 patent for his invention of an azacycloalkyl carbonyl cyclic amine compound. This compound is designed to serve as an active ingredient in pharmaceutical compositions aimed at treating neutrophil-associated inflammatory diseases. The compound is characterized by its unique formula, which includes various substituents and structural features that enhance its therapeutic potential.
Career Highlights
Throughout his career, Urakami has worked with prominent companies in the pharmaceutical industry. Notable among these are Alivexis, Inc. and Astellas Pharma GmbH. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of his notable coworkers include Takafumi Shimizu and Yoh Terada. Their collaborative efforts have further advanced the research and development of innovative pharmaceutical solutions.
Conclusion
Takeo Urakami's contributions to pharmaceutical chemistry exemplify the impact of innovative thinking in addressing complex medical challenges. His work continues to inspire advancements in the treatment of inflammatory diseases.